Newswise Feature Channel: Vaccines

LJI Discovery Paves the Way for Antivirals Against Ebola Virus and Its Deadly Relatives

La Jolla Institute for Immunology — Tue, 17 Sep 2024 17:05:16 EST

The new study, led by researchers in the Saphire Lab at LJI, reveals the inner workings of the Ebola virus nucleocapsid. LA JOLLA, CA--At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The only approved vaccine and antibody treatments protect against just one filovirus species.

T cells may offer some protection in an H5N1 'spillover' scenario

La Jolla Institute for Immunology — Mon, 16 Sep 2024 13:05:34 EST

The LJI team uncovered important similarities between H5N1 and these common viruses, which allowed them to predict that many people already have "cross-reactive" T cells that are ready to target H5N1--should it ever mutate to cause widespread disease in humans.

WashU Medicine Leads Two Major Pandemic Preparedness Research Projects

Washington University in St. Louis — Mon, 16 Sep 2024 10:05:37 EST

WashU Medicine scientists lead two large, multicenter programs to develop vaccines and antibody-based therapies for understudied viruses with pandemic potential. The programs are supported by two grants from the National Institute for Allergy and Infectious Diseases (NIAID) totaling more than $30 million a year for three years.

Albert Einstein College of Medicine Receives Major Federal Grant to Help Lead National Effort for Pandemic Preparedness

Albert Einstein College of Medicine — Fri, 13 Sep 2024 15:30:43 EST

Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious Diseases (NIAID) to participate in a broad national effort to develop "plug-and-play" vaccines and antibody-based therapies against a wide range of emerging viruses. The grant is part of NIAID's new Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network, which was announced earlier today.

Your Best Bet for Avoiding Illness from Flu and COVID-19? Getting Vaccinated.

Rutgers University-New Brunswick — Fri, 13 Sep 2024 09:05:32 EST

An infectious disease expert at Rutgers Health explains the importance of getting crucial shots this fall

New national survey shows hesitancy about vaccines this fall

Ohio State University Wexner Medical Center — Thu, 12 Sep 2024 00:05:00 EST

With flu season just around the corner and COVID-19 cases on the rise, a new nationwide survey from The Ohio State University Wexner Medical Center reveals hesitancy around vaccines this fall. The new data comes just as this year's flu shot rolls out and following the FDA's approval of an updated round of COVID-19 vaccines.

LJI Selected as Member of ARPA-H Investor Catalyst Hub Spoke Network

La Jolla Institute for Immunology — Wed, 11 Sep 2024 12:05:47 EST

La Jolla Institute for Immunology (LJI) has been selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H).

Pediatricians Highlight Role of ACIP During COVID-19 Pandemic

Wake Forest University School of Medicine — Tue, 10 Sep 2024 12:05:36 EST

The Advisory Committee on Immunization Practices (ACIP) plays a crucial role in how the Centers for Disease Control and Prevention (CDC) sets vaccination schedules for children and adults. This work was particularly critical during the COVID-19 pandemic with the remarkable advancement of vaccines amid growing public distrust of those vaccine recommendations. To highlight the ACIP's work during this challenging time, committee members are sharing their insights and experiences with a focus on pediatrics.

MD Anderson Research Highlights Special Edition: ESMO 2024

University of Texas MD Anderson Cancer Center — Tue, 10 Sep 2024 10:00:01 EST

The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.

Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD

Cancer Research Institute — Fri, 06 Sep 2024 12:20:45 EST

CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.

Global experts help nanomedicines DELIVER on healthcare promise

University of South Australia — Fri, 06 Sep 2024 05:00:00 EST

New findings from a global team of expert scientists in academia and industry has generated world-first research quality standards that will help slash costs and reduce the time it takes to develop advanced nanomedicine treatments and make them available for patients.

PhotonPharma to Present at Rocky Mountain Life Sciences Investor and Partnering Conference

PhotonPharma Inc. — Wed, 04 Sep 2024 10:05:00 EST

PhotonPharma, a pioneering biotech company focused on innovative cancer therapies, is pleased to announce its selection as a premier presenting company in the upcoming Rocky Mountain Life Sciences Investor and Partnering Conference sponsored by the Colorado BioScience Association.

COVID Shots Will Now Cost Uninsured Americans

George Washington University — Tue, 03 Sep 2024 15:05:52 EST

How to Survive Flu Season 2024

Cedars-Sinai — Tue, 03 Sep 2024 11:05:52 EST

Back to school, cooler weather, a whiff of pumpkin spice in the air. Yes, it's flu shot time.

Global Health Expert to Discuss Africa's Mpox Response and Vaccine Equity

University of the Witwatersrand, Johannesburg — Tue, 27 Aug 2024 09:40:48 EST

MSU Expert: Understand the Latest on COVID-19 and Mpox

Michigan State University — Thu, 22 Aug 2024 15:05:15 EST

San Diego scientists available to discuss mutated mpox strain

La Jolla Institute for Immunology — Thu, 22 Aug 2024 12:05:14 EST

Expert Available: FDA Approves Updated COVID-19 Vaccines

George Washington University — Thu, 22 Aug 2024 12:00:20 EST

The FDA has given the greenlight to Pfizer and Moderna for updated Covid-19 vaccines for the fall. ...

Study of 18 million people finds increased mental illnesses incidence following severe COVID-19, especially in unvaccinated people

University of Bristol — Wed, 21 Aug 2024 11:00:00 EST

A new study that examined health data on 18 million people reveals higher incidence of mental illnesses for up to a year following severe COVID-19 in unvaccinated people.

T helper cells may be the key to improving annual influenza vaccines

St. Jude Children's Research Hospital — Tue, 20 Aug 2024 10:05:28 EST

The annual influenza vaccination provides updated protection against the virus but could be improved as there is large variability in its efficacy.